novo nordisk goodrx - Search News

Order byBest matchMost fresh

Novo Nordisk slashes price of Ozempic

Novo Nordisk slashes price of weight loss drugs

Novo Nordisk is teaming up with GoodRx to offer Wegovey and Ozempic for a flat price of $499 a month. Top Air Force general to exit in Hegseth’s latest shake-up of Pentagon

· 22h · on MSN

Ozempic creator Novo Nordisk will sell weight loss drugs for cheaper through this new partnership

NJBIZ · 10m

Novo Nordisk halves Ozempic price to $499 for US patients

· 22h

Health Care Flat as Beaten-Down Stocks Rebound -- Health Care Roundup

Separately, the Food and Drug Administration approved a new indication for Novo Nordisk's blockbuster Wegovy medicine to treat a serious fatty liver disease.

· 5h

Canada approves Ozempic to cut risk of kidney failure, heart-related deaths

· 7h

Canada approves Ozempic to reduce risk of diabetic kidney disease progression

· 3h

Half-off Ozempic? US patients paying in cash can now buy the popular weight-loss drug for less

Novo Nordisk said on Monday that it would make the drug available through its direct pharmacy service for $499 per month, compared to a list price of just under $1,000 per month.

· 1d

Novo Nordisk offers lower Ozempic price for customers whose insurance does not cover costs

Becker's Hospital Review · 1d

Novo Nordisk halves Ozempic price for self-paying patients

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx shares are pulling back Tuesday morning. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk.

1don MSN

Why Novo Nordisk Stock Popped Monday

Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, jumped 5% through 9:55 a.m. ET Monday on a series of positive announcements for its GLP-1 products.

21h

GoodRx Is Soaring on a Novo Nordisk Deal. Should You Buy GDRX Stock Here?

GoodRx stock soars after announcing GLP-1 partnership with Novo Nordisk. A Bank of America analyst recommends selling GDRX shares into the strength before they crash again.

GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?

GoodRx Holdings, Inc.'s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click here to find out why GDRX is a Buy.

Stock Movers: Novo Nordisk, GoodRX, CVS

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

12h

Novo Nordisk Soars After 50% Ozempic Discount, Liver Treatment Approval

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official website.